Novo Holdings lets billions of dollars flow, bets big on Chinese and US acquisitions
Investment company Novo Holdings has a grip on the US, and is establishing a Chinese division in the coming year. Both moves are central in the strategy to acquire more, large companies, says CEO Kasim Kutay.
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
The very wealthy holding company Novo Holdings has begun the year with two billion-dollar acquisitions, and more might be underway.
As Novo Holdings tightens its grip on the US market, the firm is preparing for a big push in China.
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.